_______________________________ Developing a Safe Opioid Treatment Plant for Managing Chronic Pain
F inal E xam
DEVELOPING A SAFE OPIOID TREATMENT PLAN FOR MANAGING CHRONIC PAIN
Select the best answer for each question and mark your answers on the Final Examination Answer Sheet found on page 67, or complete your test online at BOOK.CME.EDU. A passing grade of at least 70% must be achieved in order to receive credit for this course.
11. Which of the following is one of the ten essential steps of opioid prescribing for chronic pain that can help mitigate any potential problems? A) Patient preference B) Trials of opioid monotherapy only
16. For patients considered at medium risk for misuse of prescription opioids, urine drug testing should be completed every
A) 6 to 12 weeks. B) 3 to 6 months. C) 6 to 12 months. D) 1 to 2 years.
C) Diagnosis with an appropriate differential D) A single assessment of substance abuse risk
12. Which of the following is NOT one of the 5 A’s of monitoring chronic opioid response? A) Analgesia B) Acceptance C) Affect (i.e., patient mood) D) Aberrant drug-related behaviors 13. The Current Opioid Misuse Measure (COMM) consists of A) 5 items.
17. When using urine drug testing to monitor adherence and compliance, it is important to A) understand the limitations. B) always use manufacturer recommended testing frequency. C) use immunoassay point-of-care results as the basis of important clinical decisions. D) aggressively confront patients with results suggesting non-use of a prescribed opioid. 18. When prescribing opioids, clinicians should provide patients with instructions to A) immediately halt an opioid if the side effects are unacceptable. B) never break or chew/crush tablets or cut or tear patches prior to use. C) share opioids with friends and relatives that cannot afford their own prescriptions. D) take other central nervous system depressants to manage opioid side effects. 19. The U.S. Food and Drug Administration recommends that unused OxyContin tablets be disposed of by A) burning. B) flushing down the toilet. C) throwing in the garbage in a sealed container. D) sharing with a friend or relative with chronic pain. 20. An opioid should be safely discontinued with A) inadequate analgesia. B) resolution of the pain syndrome. C) significant aberrant medication use. D) All of the above
B) 17 items. C) 25 items. D) 40 items.
14. The Pain Assessment and Documentation Tool (PADT) was designed to address what shortcoming(s) in chronic pain management? A) Suboptimal physician-patient communication B) Inappropriate and/or excessive opioid prescriptions C) Deficits in chart notes and progress documentation D) Lack of knowledge regarding mutual responsibilities and expectations 15. Family members of patients prescribed opioids for the treatment of pain may contribute to the safe use of these agents by A) reporting whether a patient’s mood is worsening (e.g., depression) while on opioid therapy. B) observing whether a patient is losing control of his or her life during the course of opioid therapy. C) providing input regarding positive or negative changes in patient function, attitude, and level of comfort. D) All of the above
Course Code: MDNJ01SO
21
MDNJ1525
Powered by FlippingBook